STOCK TITAN

Quotient Limited to Report First Quarter Fiscal 2023 Financial Results and Host Conference Call on August 9th

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Quotient Limited (NASDAQ: QTNT) will release its financial results for the fiscal first quarter ending June 30, 2022, before the market opens on August 9, 2022. The company's conference call will occur at 8:30 AM ET, with key speakers including CEO Manuel O. Méndez and CFO Ali J. Kiboro. Quotient is focused on transforming diagnostics with its innovative MosaiQ technology, enhancing efficiency and cost-effectiveness for laboratories globally.

Positive
  • Quotient's MosaiQ technology is positioned as a game-changer in diagnostics.
  • The upcoming financial results may present opportunities for market engagement.
Negative
  • None.

JERSEY, Channel Islands, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2022 will be released before market open on Tuesday, August 9, 2022.

Title:

Quotient First Quarter Fiscal 2023 Financial Results and
Conference Call
 
Speakers:Manuel O. Méndez, Chief Executive Officer
Ali J. Kiboro, Chief Financial Officer
Date:Tuesday, August 9, 2022
Time:8:30am ET/ 14:30 CET
Conference Call Dial-in Details:

International: 201-689-8560
Switzerland: 0800 835 525
United Kingdom: 0800 756 3429
US: 877-407-0784
Conference ID: 13731396



Webcast:Webcast Link - Click Here

Quotient Events & Presentations

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Quotient Limited
Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. The MosaiQ solution, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. The MosaiQ solution is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, and deliver significant workflow improvements and operational cost savings to laboratories around the world. Quotient’s operations are based in Switzerland, Scotland, US, and the UAE.

The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

CONTACT: Investor Relations, ir@quotientbd.com; +41 22 545 52 26


FAQ

When will Quotient Limited release its financial results for Q1 2023?

Quotient Limited will release its financial results on August 9, 2022.

What time is the Quotient Limited conference call scheduled for?

The conference call is scheduled for 8:30 AM ET on August 9, 2022.

Who will be speaking during the Quotient Limited conference call?

Manuel O. Méndez, CEO, and Ali J. Kiboro, CFO, will be speaking.

What is the significance of the MosaiQ technology for Quotient Limited?

The MosaiQ technology aims to improve efficiency and reduce costs in diagnostics.

Quotient Ltd

NASDAQ:QTNT

QTNT Rankings

QTNT Latest News

QTNT Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Switzerland
Eysins